Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Assessing quality of life in Alzheimer's disease: Implications for clinical trials.

Kahle-Wrobleski K, Ye W, Henley D, Hake AM, Siemers E, Chen YF, Liu-Seifert H.

Alzheimers Dement (Amst). 2016 Dec 13;6:82-90. doi: 10.1016/j.dadm.2016.11.004. eCollection 2017.

2.

Examining the Pathways Between Self-Awareness and Well-Being in Mild to Moderate Alzheimer Disease.

Cines S, Farrell M, Steffener J, Sullo L, Huey E, Karlawish J, Cosentino S.

Am J Geriatr Psychiatry. 2015 Dec;23(12):1297-1306. doi: 10.1016/j.jagp.2015.05.005. Epub 2015 May 19.

3.

Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model.

Yang SH, Kim J, Lee MJ, Kim Y.

Sci Rep. 2015 Oct 27;5:15703. doi: 10.1038/srep15703.

4.

Neuropsychiatric Symptoms in Posterior Cortical Atrophy and Alzheimer Disease.

Suárez-González A, Crutch SJ, Franco-Macías E, Gil-Néciga E.

J Geriatr Psychiatry Neurol. 2016 Mar;29(2):65-71. doi: 10.1177/0891988715606229. Epub 2015 Sep 24.

5.

Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.

Leoutsakos JM, Forrester SN, Lyketsos CG, Smith GS.

J Alzheimers Dis. 2015;48(2):483-93. doi: 10.3233/JAD-150421.

6.

Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, Agüera-Ortiz L, Sweet R, Miller D, Lyketsos CG; ISTAART Neuropsychiatric Symptoms Professional Interest Area.

Alzheimers Dement. 2016 Feb;12(2):195-202. doi: 10.1016/j.jalz.2015.05.017. Epub 2015 Jun 18.

7.

Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer's disease.

Hall JR, Wiechmann AR, Cunningham RL, Johnson LA, Edwards M, Barber RC, Singh M, Winter S, O'Bryant SE; Texas Alzheimer’s Research and Care Consortium.

Alzheimers Res Ther. 2015 May 1;7(1):24. doi: 10.1186/s13195-015-0107-4. eCollection 2015.

8.

Depressive symptoms are associated with analgesic use in people with Alzheimer's disease: Kuopio ALSOVA study.

Gilmartin JF, Väätäinen S, Törmälehto S, Bell JS, Lönnroos E, Salo L, Hallikainen I, Martikainen J, Koivisto AM; ALSOVA Study Group.

PLoS One. 2015 Feb 17;10(2):e0117926. doi: 10.1371/journal.pone.0117926. eCollection 2015.

9.

The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study.

Hallikainen I, Martikainen J, Lin PJ, Cohen JT, Lahoz R, Välimäki T, Hongisto K, Väätäinen S, Vanhanen M, Neumann PJ, Hänninen T, Koivisto AM.

Dement Geriatr Cogn Dis Extra. 2014 Dec 11;4(3):494-508. doi: 10.1159/000369159. eCollection 2014 Sep-Dec.

10.
11.

Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.

Gitlin LN, Marx KA, Stanley IH, Hansen BR, Van Haitsma KS.

Int Psychogeriatr. 2014 Nov;26(11):1805-48. doi: 10.1017/S1041610214001537. Epub 2014 Aug 6. Review.

12.

Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol.

Tan EC, Visvanathan R, Hilmer SN, Vitry AI, Quirke T, Emery T, Robson L, Shortt T, Sheldrick S, Lee SS, Clothier R, Reeve E, Gnjidic D, Ilomäki J, Bell JS.

BMJ Open. 2014 Jun 19;4(6):e005757. doi: 10.1136/bmjopen-2014-005757.

13.

Factors associated with caregiver burden in patients with Alzheimer's disease.

Kang HS, Myung W, Na DL, Kim SY, Lee JH, Han SH, Choi SH, Kim S, Kim S, Kim DK.

Psychiatry Investig. 2014 Apr;11(2):152-9. doi: 10.4306/pi.2014.11.2.152. Epub 2014 Apr 11.

14.

Depression in cognitive impairment.

Pellegrino LD, Peters ME, Lyketsos CG, Marano CM.

Curr Psychiatry Rep. 2013 Sep;15(9):384. doi: 10.1007/s11920-013-0384-1. Review.

15.

Correlates of quality of life for individuals with dementia living at home: the role of home environment, caregiver, and patient-related characteristics.

Gitlin LN, Hodgson N, Piersol CV, Hess E, Hauck WW.

Am J Geriatr Psychiatry. 2014 Jun;22(6):587-97. doi: 10.1016/j.jagp.2012.11.005. Epub 2013 Jul 25.

16.

Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.

Trzepacz PT, Saykin A, Yu P, Bhamditipati P, Sun J, Dennehy EB, Willis B, Cummings JL; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2013 Jul;21(7):607-22. doi: 10.1016/j.jagp.2012.10.027. Epub 2013 Apr 18.

17.

Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease.

Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, Winter AS, Singh M, O'Bryant SE.

J Alzheimers Dis. 2013;35(2):363-71. doi: 10.3233/JAD-122359.

18.

Management of patients with Alzheimer's disease: pharmacological treatment and quality of life.

Mossello E, Ballini E.

Ther Adv Chronic Dis. 2012 Jul;3(4):183-93. doi: 10.1177/2040622312452387.

19.

Nonpharmacologic management of behavioral symptoms in dementia.

Gitlin LN, Kales HC, Lyketsos CG.

JAMA. 2012 Nov 21;308(19):2020-9. doi: 10.1001/jama.2012.36918.

20.

Reduced quality-of-life ratings in mild cognitive impairment: analyses of subject and informant responses.

Teng E, Tassniyom K, Lu PH.

Am J Geriatr Psychiatry. 2012 Dec;20(12):1016-25. doi: 10.1097/JGP.0b013e31826ce640.

Supplemental Content

Support Center